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a b s t r a c t
Semiconductor nanoparticles also known as quantum dots (QDs) have continued to receive more
attention from researchers due to their unique optical, magnetic and photo physical properties which
made them useful as biomedical materials, solar cells, catalyst etc. However, ternary I–III–VI QDs have
shown to be a safer alternative to the binary II–VI or IV–VI QDs due to the absent of heavy toxic
elements such as Cd and Pb. Cancer management and therapy in Africa has been bedevilled by a lot
of challenges such as inaccurate diagnosis and ineffective therapeutic methods. Therefore, the need
to develop an appropriate approach for cancer detection and treatment is of paramount importance.
Tunable optical properties and absorption in the near infra-red region of the ternary QDs makes
them useful as fluorescent probes in cancer detection and treatment. They have the ability to detect
specific cancer cells including those that are not easily detected by modern imaging technique. Also,
properties such as non-bleaching, stability, water solubility etc. made them a desirable fluorophore
when compared to conventional dyes. Most cancer drugs suffer from inherent shortcomings such
as limited absorption, insolubility and aggregation. However, these shortcomings can be overcome
when these drugs are applied in form of conjugated systems. The use of QDs as conjugates has
revolutionise the treatment of cancer in the 21st century. This review provides information about
the synthesis strategies, optical properties, hydrophilization and bioconjugation of ternary I–III–VI QDs.
Furthermore, we described the various biomedical applications in biosensors, bioimaging, drug delivery
and phototherapeutic techniques. Finally, we looked at the challenges and future perspective of these
QDs in cancer management.
© 2020 Elsevier B.V. All rights reserved.
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Cancer management globally has been challenging. Globally,
round 9.6 million cancer related cases were recorded in 2018
nd new cases rose to 18.1 million [1]. The cancer burden is
rojected to double by 2035 [2]. This figure exceeds the death
rom malaria, HIV and tuberculosis combined and thus calls for
erious action. Non-availability of cancer treatment facilities and
ittle or no access to conclusive diagnoses at various hospitals
n developing countries have been major setbacks in tackling
his terminal ailment. Accurate diagnosis through the excellent
maging of cancer cells, drug effectiveness and ability to deliver
he cancer drug to the specific site are all essential for proper
ancer management. Most cancer cases are detected after the
umour have been developed which makes the treatment difficult
nd sometimes ineffective. On the other hand, most cancer drugs
uffer from inherent shortcomings such as limited absorption,
nsolubility and aggregation. However, these shortcomings can be
vercome when these drugs are applied in the form of conjugated
ystems [3,4].
Quantum dots (QDs) are semiconductor nanomaterials with
nherent ability that allows them to emit fluorescence when
xposed to light [5,6]. QDs have continued to receive more atten-
ion from researchers due to their unique optical, magnetic and
hoto-physical properties which made them useful as biomedical
aterials, solar cells, catalyst and so on [7].
Ternary QDs from group I–III–VI elements have received grow-
ng interest in cancer management owing to their lower toxicity
nd radiation stability. Due to their specificity and biosensitivity,
ernary QDs conjugates has the potential of detecting specific
ancer cells (such as HeLa cells and HER-2 breast cancer cells)
ncluding those which are not easily detected by modern imaging
echniques such as Magnetic Resonance Imaging (MRI) and X-rays
8,9].
Furthermore, conjugated ternary QDs can also be used for tar-
eted drug delivery i.e delivery of the cancer drug to where it will
e most effective without harming the healthy tissues. This ulti-
ately ensure effective treatment under small amount and lower
ost of medication. Ternary QDs also possess photothermal prop-
rties which can heat the cancer cells when used as conjugates
ith cancer drugs [5,10]. Exploiting specific binding properties
f QDs conjugates as a mechanism for selective delivery of cancer
rugs to tumour cells would be a major solution to the menace
f cell-killing agents for treating cancer. Apart from ternary QDs,
ertain studies have also described carbon based QD (such as
arbon quantum dots, graphene quantum dots, C3N quantum
ots, and g-C3N4 quantum dots) as a non-toxic QD useful for
iological and biomedical applications [11–13]. However, they
iffer from ternary I–III–VI QD in terms of composition, structure
nd mostly importantly in fluorescence ability [14].
The biomedical and biological applications of ternary QDs
ave been reported by several authors [15,16]. In this review,
ost of the reference materials are related to the application of
ernary QDs in biomedical applications for cancer treatment. We
ill be looking at the various synthetic approach, the techniques
mployed in improving photoluminescence, quantum yield andoptical properties of QDs as it relates to their core shell systems.
Furthermore, we will also study the biological applications of
ternary QDs particularly AIS, CuInS and CuInSe in drug delivery,
imaging, biosensor, bioconjugation etc. The toxicity of these QDs
will also be discussed.
2. Key concept of ternary QDs
Unlike binary QDs, ternary I–III–VI QDs (I = Cu or Ag, III
= Ga or In and VI = S or Se) consist of less toxic elements
(devoid of Cd, Hg etc.). They are regarded as promising candidates
for developing QDs that are eco-friendly due to their favourable
optical properties and low toxicity [17]. Optical properties of QDs
can be tunable due to quantum confinement effect. Quantum
confinement takes place when the QDs attain a size less or equal
to that of the Bohr’s radius [18–20].
Variances in the atomic composition of ternary QDs distorts
their size, this distortion in size affects the band gap. The change
in band gap and size permits them to emit photons from the
visible to the near infra-red region. The emission of photons as
a result of variance in atomic composition enables the tuning of
the absorption spectra [21,22]. Their usefulness in bio imaging,
phototherapy, drug delivery and biosensing can be attributed to
their size dependent optical properties and tunable emissions to
the near infrared region [23,24]. Ternary QDs showed band gaps
of 1.05 eV, 1.5 eV, 1.87 eV and 1.2 eV for CISe, CIS, AIS and AISe
respectively [25,26]. In addition to this, ternary QDs are found
to have a large coefficient of absorption, excellent photostability,
high quantum yield, good luminescence decay time and large
stoke shift [27–29]. Tunable emission spectra of ternary I–III–VI
QDs makes them a good candidate for biomedical applications as
fluorescence is an important parameter for majority of medical
research [30,31].
2.1. Ternary QDs core/shell system
Ternary I–III–VI QDs synthesised as core QDs show low quan-
tum yield and surface defects [32,33]. This occurs due to their
high surface to volume ratio as a result of their small size. There-
fore, adequate surface passivation is important to ensure increase
in quantum yield, fluorescence and stability. In other to improve
quantum yield, ensure stability and minimise or reduced surface
defect, the core surface is usually coated with shell materials
possessing a larger band. The choice of shell materials is depen-
dent on the desired application of the QDs. The use of Zn2+ and
nS as shell materials for ternary QDs with focus on biological
pplications are widely discussed in this review. Core/shell QDs
ystems allows for the modification of properties for suitability in
arious biomedical and industrial applications. Thermal stability,
ispersibility and functionality of the core can be modified when
oated with appropriate shell material.
Taking into consideration, band alignment between the con-
uction and valence band of the core materials, core/shell QD
ystems can be classified into type I, type II and quasi type II [17,
4]. In type I core/shell systems, the energy of the conduction
and of the core is lower than that of the shell while reverse
s the case for the valence band [34]. The holes and electrons
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electrons and holes are present in two different compartments,
causing the rate of recombination of the charged carriers to be
slow. The slow rate of recombination of the charge carriers is
the reason for the increased luminescence lifetime exhibited by
type II core/shell systems [35]. In Quasi type II core/shell systems,
one carrier is localised in the core or shell while the other is
delocalised as a whole particle.
ZnS is much preferred as a shell material due to the following
reasons; (i) wider band gap (3.7 ev) and a small ionic size of
zinc, this enables proper band alignment with the ternary QDs
(ii) the structure of ZnS ensures the removal of trap states and
prevents leakage caused by the charge carriers in the ternary
QDs [36,37]. In another study, Speranskaya et al. [38] reported
a 52% improvement in photoluminescence quantum yield (PLQY)
after shelling CIS core with ZnS. The schematic representation for
the synthesis of CIS/Zn core/shell system is shown in Fig. 1. The
emission range of these core/Zn shells make them suitable for
biological application. Studies have confirmed the suitability of
ZnS as shell materials with ternary QDs. With CuInS2 core, Chen
et al. [39] reported a QY of 48% and PL of 500–800 nm; Huang
et al. [40] reported a QY of 88% and PL of 400–800 nm to mention
a few.
2.2. Synthesis of ternary I-III-VI QDs
The synthesis of ternary QDs can be challenging and their
chemistry can be complex owing to the chemical properties of
the precursor cations. In3+ is a hard lewis acid while Cu+ and
Ag+ are soft lewis acid. Due to this, their reaction with sulphur
compounds leads to the formation of unbalanced cationic precur-
sors. Consequently, the product formed contains more of copper,
silver and indium sulphides than the ternary QDs. To achieve
good reaction yield, the reactivity of Cu and In has to be regulated.
This can be achieved through; (i) the use of a suitable capping
ligand e.g carboxylic acid, thiols (ii) the use of stabilising agents
(iii) using a single precursor which can produce both cations (Cu
and In) precursors [42,43].
Several methods for the synthesis of ternary I–III–VI QD core
shell systems have been reported (see Fig. 2, Tables 1 and 2). They
include; hot injection method [44,45], solvothermal method [46,
47], microwave assisted method [48], hydrothermal [26,49] and
heating up method [33,50]. During synthesis, factors such as
temperature and time, temperature of injection (particular to hot
injection method), pH, nature of solvent utilised, reactivity and
stoichiometry of precursors are vital to ensure the desired size
and composition of the QDs.
2.2.1. Hot injection method
This method involves the reaction of precursors and surfac-
tants at very high temperature in the presence of stabilisers.
Coordinating solvent and surfactants are heated in a reacting
chamber in the presence of an inert gas (nitrogen or argon).
After which precursors are rapidly injected into the hot solution
leading to supersaturation. Consequently, the precursors become
aggregated therefore inducing nucleation and growth of the nu-
clei. The size distribution of the QDs is dependent on the speed
of injection. Narrow size distribution is enhanced through fast
injection. This method of synthesis is associated with monodis-
persed QDs. It is said to be a technique that gives high qual-
ity and pure QDs [34]. Researchers have employed this method
in the synthesis of ternary QDs. Zhong et al. [20] synthesised
CuInSe with photoluminescence quantum yield (PLQY) of 50%
for in vivo bio-imaging applications; Liu et al. [51] synthesised
AgInS2, with PLQY of 30% and emission peak in the range of 480–
900 nm. In another development, Deng et al. [52] synthesised
AISe2 with PLQY of 40%, and emission peak also in the range of
600–1000 nm. ZnS was used as shell materials to improve the
optical properties of the QDs in all of the highlighted cases.2.2.2. Heating up method
This method can also be referred to as the non-injection
method. Reaction solutions are prepared at low temperature and
heated up for crystallisation to take place at a high temperature.
The heating up process is achieved via decomposition of metal
salt in the presence of surfactant and solvent with high boiling
point. The size distribution of the QDs is determined by nature of
crystallisation and the reactivity of the precursors determines the
reaction temperature. In this method, supersaturation is instan-
taneous and accompanied by a fast crystallisation. This method
is effective for size, morphology and elemental control of the
QDs. CuInS2/ZnS [36], AgInTe2 /ZnS [53] and AgInSe2 [54] have
been produced using heating up approach with emission peak in
the range of biomedical applications. This synthetic approach is
suitable for large scale synthesis as large amount of precursors
can be used in a large volume reactor.
2.2.3. Solvothermal method
This approach offers several advantages when compared to the
other synthetic methods. The synthesis environment enhances
the formation of crystals with little lattice defects leading to
the effective control of the shape and size distribution of the
QDs. Secondly, the use of low boiling point organic solvent per-
mits a higher reaction pressure when reaction occur at a higher
temperature. This behaviour largely affects the crystallinity of
the QDs. Thirdly, certain structural properties of the precursors
can be transferred to the product for the effective control of
the morphology of the products. Finally, this process consumes
less energy and does not involve the use of costly solvents.
CuInSe2/ZnS [55], CuInSe2 [56] and CuInS2 [57] have been synthe-
sised via the solvothermal approach with emission peaks in the
range of biomedical applications. Solvothermal synthesis reduces
the release of harmful vapour during reaction making the process
environmentally friendly.
2.2.4. Hydrothermal method
In the field of nanochemistry, green chemistry approach for
the synthesis of nanoparticles is highly desirable. Cost effective-
ness and environmental friendliness of the process is the aim
of most researchers. One of the advantages of this method is
the use of non-toxic solvent and reagents. This process does not
necessary require synthesis in an inert atmosphere thus making
the synthesis cost effective. The synthesis is achieved by the
reaction between a metal precursor and surface ligands. The pre-
cursor used are mostly water-soluble metallic nitrates and halide
while the sulphur sources are usually Na2S [58] and thiourea
(CS(NH2)2 [59]. The advantage offered by this approach include;
(i) good product yield (ii) use of non-toxic solvent and reagents
(iii) low cost of synthesis (iv) reproducibility [60,61]. The first
attempt of synthesising AIS by Luo et al. [62] using this method
resulted into a low QY. However, for effectiveness in bio-medical
applications it is necessary for QDs to have a high QY, to be water
dispersible and to be biocompatible. Several studies have shown
that the use of hydrophilic ligands as sulphur sources such as do-
decanethiol [27], l-Cysteine [63] and diethyldithiocarbonate [64]
have produced water soluble ternary QDs with good QY suitable
for biomedical applications.
2.2.5. Microwave irradiation method
Synthesis of ternary QDs using microwave irradiation tech-
nique is gaining much attention due to the numerous advantages
it offers. In this method, the synthesis is carried out at the boil-
ing point of the solvent, therefore enabling the production of
small particle size QDs at normal pressure. The product formed
is of high purity with a fast reaction time. Reproducibility and
product yield are also enhanced. AIS QDs was synthesised using


























































































he microwave assisted approach by Xiong et al.a [65] via a
wo-step approach and using ZnS as shell material. The product
btained showed low toxicity, good fluorescence and emission
ange suitable for in vivo bio-imaging application. QDs have been
ynthesised by various researchers using this synthetic approach.
gInS2 [66], CuGaSe2 [67] CuInS2 [68]. The small size, biocompat-
bility and thermal stability of these QDs makes them useful for
iological applications [17].
. Hydrophilization of ternary QDs
Fluorescent QDs of high quality are usually synthesised using
on-polar solvent at a high temperature, as a result they have
ydrophobic surfaces. This can be attributed to the presence of
liphatic amines, carboxylic acids, alkyl phosphines etc. Mean-
hile for effective applications of these QDs in cancer manage-
ent they require water dispersibility, biocompatibility and pres-
nce of active sites for subsequent functional conjugation. There-
ore, functionalisation of their surface is mandatory to ensure
olubility in aqueous solutions. Strategies need to be employed
or the conversion of the hydrophobic phase to hydrophilic. There
re three strategies to this as shown in Fig. 3. These are; ligand
xchange, Salinisation and encapsulation [79–81].
Ligand exchange is achieved by substituting the hydrophobic
urface of the QDs with hydrophilic molecules that can easily bind
ith the QDs surface. The surface ligand ensures the QDs are dis-
ersed in aqueous media and also protects the core from leaching
nto the biological environment. These conditions are essential
or successful in vitro and in vivo biological applications [82].
idely used ligands are thiol groups (due to their affinity for
etals), amines and carboxylic acids [83]. In this approach, the
ydrodynamic size of the QDs is retained and allows for monodis-
ersity of the QDs in aqueous media. This improves their ability
or FRET based sensing and makes them good candidates for bi-
logical applications [84]. When choosing the appropriate ligand,
tmost consideration should be given to the affinity that exist
etween the ligand and the QDs. However, some limitations are
ssociated with this method, conditions such as concentration,
H and temperature affect the stability of the attached ligand.
n order to overcome this limitation and to create opportuni-
ies for wider biological applications, thiol containing molecules
uch as L-cysteine [85] and polyethylene glycol-dihydrolipoic acid
PEG-DHLA) [86] have been used for the functionalisation and
olubilisation of QDs with a major improvement in in vivo and
n vitro stability. Kim et al. [87] in their work on the synthe-
is of CuInS2/Zn core/shell quantum dots replaced the initially
liphatic capped surface ligand with a hydroxyl-terminated thiol
igand. The functionalised QDs displayed improved dispersibility
n polar solvents. The synthesis of 1-dodecanethiol (DDT) cappeduInS2/ZnS QDs was reported by Li et al. [88]. The QDs was
ransferred to the aqueous phase by functionalising the surface
ith DHLA. The functionalised QDs was successfully used as
abels for in vivo imaging. The main difficulty encountered in this
ethod is the susceptibility to oxidation of the thiol group and
he attached ligand. This can further degenerate to the reduction
n fluorescence QYs and formation of aggregates.
The salinisation method is based on the well-known silica
hemistry developed for the coating of metallic nanoparticles.
his method has advantages due to the non-toxicity, inertness
nd optical transparency of the coated silica surface. In this
pproach, a formation of highly linked protective shell takes
lace around the QDs. This is due to the reaction between poly-
erised methoxysilane groups and the thiol group of the pre-
ursor molecule used for hydrophilisation of the QDs surface.
ercaptopropyltrimethoxysilane (MPTMOS) is a typical example
f a precursor used for this purpose [89]. The major advantage of
his method is that silica exhibits a high level of biocompatibility
nd can be easily functionalised thereby making them suitable
or conjugation. Consequently, QDs emanating from this approach
re good candidates for bioanalytical applications [90].
In the third approach, the surfaces of QDs are encapsulated
ith amphiphiles with the use of non-polar molecules as reac-
ion intermediates. The hydrophobic shell of QDs interacts with
hat of the amphiphilic polymeric material through electronic
r hydrophobic interaction while the hydrophilic portion en-
ures solubility thereby providing aqueous stability. Several am-
hiphilic polymers have been used in this approach, such as
olymaleic anhydride [91], Polyacrylamide [92] or biopolymers
uch as DNA/RNA [93]. Polyethylene glycols (PEG)-based coating
re applied to the QDs to ensure stability and biocompatibility.
owever, for effective application of these QDs in bioanalytical
rocesses, it is important for the PEG molecules to be activated
ith the suitable thiol, amine or carboxylic groups in order to
nable the formation of hydrophilic cross links between the QDs
urface and the PEG layer [94,95]. This method is an improvement
n the ligand exchange method as it addresses the shortcomings
f aggregation and poor luminescence quantum yield. In this
pproach, the optical properties and size of this QDs remain
nchanged.
Surface modification and functionalisation of QDs is important
o ensure stability, solubility in various solvents and for the
evelopment of a QD-biomolecule conjugate that will be useful
n specific biomedical applications such as detection, bioimaging
nd therapeutics.
. Bioconjugation to biomolecules
For water soluble QDs to be relevant in biomedical appli-
ations such as bioimaging, drug delivery and other biological
O.A. Aladesuyi and O.S. Oluwafemi / Nano-Structures & Nano-Objects 24 (2020) 100568 5Fig. 2. Mechanism of various synthetic methods: Illustration of various synthetic strategies (i) Hydrothermal (ii) microwave irradiated (iii) solvothermal (iv) hot
injection and (v) heating up method for synthesis of I–III–VI core and core/shell QDs [34].Table 1
Characteristics of different synthetic methods of tertiary QDs.
Synthetic method Advantage Disadvantage
Solvothermal Size control, minimal release of toxic vapours, control of
morphology and crystallinity of the QDs
Requires the use of organic solvent
Hot Injection Size control and good QY An inert atmosphere is required, use of organic
solvent not suitable for large scale synthesis
Heating up method Effective for large scale synthesis and reproducibility Carried out at high temperature and organic is
solvent required
Hydrothermal Cheap, environmentally friendly and water soluble Low photoluminescence QY and poor size control
Microwave irradiated Environmentally friendly, energy consumption is low, pressure
and temperature can be controlled, rapid nuclear growth,
reduced time of crystal formation and narrow size distribution
Low PLQYTable 2
Overview of synthetic methods and applications of tertiary QDs.
Synthetic method QD NP Application Reference no
Solvothermal AISe2
CIS/ZnS



























High contrast cell imaging
Biodetection and bio-imaging
[77]
[78]applications they must be bonded to functional biomolecules
such as proteins, enzymes, antibodies and nucleic acids [97].Irrespective of the final use, the application of QDs in biological
systems is dependent on their ability to undergo bioconjugation
in a well-controlled and desired manner. An assembly that pairs a
6 O.A. Aladesuyi and O.S. Oluwafemi / Nano-Structures & Nano-Objects 24 (2020) 100568Fig. 3. Approaches to hydrophilization of QDs [96].QDs to a biological molecule regardless of the chemistry of bond-
ing is known as a QDs conjugate [98]. In biological applications
of QDs, the biomolecule should be attached in such a manner
that the inherent properties of the QDs will not be distorted. Bio-
conjugation of biomolecules to QDs surfaces involves two main
approaches: Covalent linking and non-covalent binding [96]. In
covalent conjugation, molecules are coupled to the QDs surface
or the ligand attached to the QDs with the help of cross-linking
molecules with reactive functional groups. For conjugation of
functional biomolecules to take place there must be different
binding affinities. This include the use of bifunctional ligand such
as mercaptopropionic acid (MPA) and DHLA which can join the
QDs surface to the biomolecule including proteins (albumen, anti-
bodies) and nucleic acids [99]. An appreciable number of possible
reactions by which biomolecules can be bonded covalently with
surface ligands of QDs have been described in literature [96,
98,100]. They include bonding through biotin/streptavidin [101],
1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) and N-
Hydroxysuccinimide (NHS) coupling [102].
Non-covalent conjugation strategy involves the electrostatic
attachment between the biomolecule and QDs surface, and en-
capsulation or adsorption on the surface using engineered protein
molecules. This approach involves the non-specific adsorption
of molecules such as polymers, protein, enzymes and so on.
Adsorption is made possible due to the large surface area of the
QDs which enables the non-selective binding of the molecules
independent of any functional attachment [80]. The mechanism
of adsorption is based on electrostatic interaction with the QDs
surface and oppositely charged biomolecules [101]. The choice
of the method to use is based on certain properties of the QDs
such as chemical composition, the presence or absence of ligands
and active sites, size of the QDs and the chemical nature of the
QDs [89]. Due to the large area to volume ratio, series of different
biomolecule can be attached to a single QDs for multifunctioning.
Several studies have shown that surfaces of ternary QDs con-
jugated with biomolecule in a well-controlled manner has the
ability of binding, adsorbing and transporting drugs and protein.
This, makes them good candidates for cancer management in
relation to detection, drug delivery to mention a few. Tsolekile
et al. [5] carried out the synthesis of TPPS4–CuInS/ZnS conjugates,
results from the study showed an improved singlet oxygen quan-
tum yield from 0.19 before conjugation to 0.69 upon conjugation
(Fig. 4). In another study, Michalska et al. [103] synthesised
ZCIS-peptide conjugate as nanoprobe for cancer imaging. The
result from the study reveals that the conjugates was effective as
fluorescence nanoprobes for selective labelling of HER2-positive
cancer cells (Fig. 5)5. Biomedical applications of ternary QDs
Core and core/shell QDs have found several applications in
the field of biomedicine. A lot of studies have been carried out
with regards to this [104–106]. Ternary QDs have been used for
in vivo and in vitro imaging, detection/localisation, and treatment
of cancer cells due to their unique properties such as broad ab-
sorption range in the NIR region, narrow emission, phototherapic
abilities, large stoke shift etc. Precisely, they find applications in
biosensing, targeted drug delivery system, bio-imaging and tissue
engineering.
In this section we provided a general overview on certain
biomedical applications of ternary QDs.
5.1. Biosensors
Fluorescent biosensors have been used for the effective diag-
nosis of diseases at the cellular level. In comparison with con-
ventional organic dyes and fluorophores, QDs displays better
photo-chemical and photophysical properties therefore, making
it them a better candidate for fluorescence probes in biosensing
applications. Ternary QDs are however considered more ideal
due to their stability, low toxicity and affordability as against Cd
based QDs. Fluorescence resonance energy transfer (FRET) QD-
based biosensors have been widely used for the detection of
biomolecules such as sugars, DNA, RNA, cancerous cells, cancer
biomarkers etc. [107,108]. Renuga et al. [109] synthesised CuInS2
– based core multishell nanocrystals with low cytotoxicity and
described their usefulness as an effective bioimaging probe and,
as an attractive candidate as biological contrasting agent.
Immunoassay is important in regard to clinical diagnosis, test-
ing and biomedical applications. QD-based sensing immunoassay
showed detection of toxins, drug residues, chemical residues,
and biomarkers. Xiong et al.b [110] used CuInS2/ZnS NPs as sig-
nal labels for a fluoroimmunoassay of the biomarker IL-6, and
they were found useful in applications for biomarkers of cancer.
Zhu et al. [111] used QD based immunoassay for the detection
of water pathogens. Biotinylated antibody was coupled to the
coated QDs and the result showed an improvement over the
conventional staining kits due to better photostability of the QDs.
They also observed a much-improved signal to noise ratio for
the QDs. Anti-body conjugated QDs was used for multicolour
cellular staining by Wu et al. [112] The study revealed that
the QDs showed more resistance to photobleaching (oxidation
process that makes them lose their fluorescence) relative to the
O.A. Aladesuyi and O.S. Oluwafemi / Nano-Structures & Nano-Objects 24 (2020) 100568 7Fig. 4. Schematic illustration of the conjugation of CIS/ZnS and meso-tetra-(4-sulfonatophenyl) porphyrin (TPPS4) [5].Fig. 5. Schematic illustration of CuInZnxS2+x QDs conjugated with peptide [103].conventionally used organic dyes under constant illumination.
Antibodies conjugated QDs can be applied for the detection of
cancer biomarkers in immunoassays. More research work is still
required to be carried out on the copper and silver ternary QDs
to explore their potential towards biomedical applications.
5.2. Bioimaging applications
Imaging is an essential modality used in deciding an effi-
cient cancer therapy. Imaging tools are important for diagnostics
and therapeutic monitoring processes, and they have been used
extensively in cancer therapy [113]. However, modern imaging
techniques has some limitations. They are not very sensitive to
small number of malignant cells and the inability to locate spe-
cific cancer cell surface markers. In a lot of cases, these cell surface
markers assist in the diagnosis of cancerous growth. Therefore, it
is important to improve on imaging techniques or develop very
sensitive and biospecific imaging probes. Ternary QDs due to their
excellent properties such as narrow tunable emission spectra,
non-toxicity, photo-physical properties have been used in bio-
imaging applications such as magnetic resonance imaging (MRI)
and optical imaging [5,114].
5.2.1. Magnetic resonance imaging (MRI)
Unique features such as non-invasiveness and strong contrast
in soft tissues makes MRI a valuable imaging tool for cancer
diagnosis. MRI produces the 3D image of the human body without
using an ionisation radiation. MRI images consist of two imaging
modes; longitudinal weighed (T1) and transverse (T2) weighed
images [17]. In order to achieve molecular imaging in MRI, tar-
geted contrast agents are necessary. These contrast agents have
the ability of speeding up the T and T relaxation rate in cancer1 2cells which in turn increase the contrast between normal and
cancer cells. Metallic doped magnetic ternary I–III–VI QDs are
widely used as contrast agents in MRI measurements due to their
absorption in biological window and fluorescent transitions. In
their work Yu et al. [115] prepared Gd doped CIS/ZnS QD using
the hot injection method and used it as a biomodal bioimaging
nanoprobe. The results showed the doped CIS/Zn QDs produced
an enhanced MRI contrast while still exhibiting strong PL emis-
sion. Furthermore, Yang et al. [116] in their study ascertained that
Gd (III) chelate conjugating CIS QDs can enhance NIR fluorescence
and MRI imaging.
5.2.2. Optical imaging
In biomedical research, optical imaging is important in pro-
viding in vivo and in vitro information with high resolution. This
imaging tool can provide multiple images thereby giving it use-
fulness for surgery and endoscopic processes. It is also employed
for image guided surgical operation of tumours and detection
of cancer cells. Due to their unique properties such as high QY,
high resistance to photobleaching and long photoluminescent
lifetime, ternary QDs can be used for targeted fluorescence imag-
ing where tissues or cells are labelled with ternary QDs. This
is applicable to both in vivo and in vitro processes. Regulacio
et al. [117] in their study synthesised luminescent AgInS2-Zn
QDs (ZAIS), the synthesised QDs exhibited long fluorescence life-
times, optical and colloidal stability in physiologically relevant pH
values with a relatively low cytotoxicity and has high potential
for use in biological labelling The authors demonstrated that


















































































































the synthesised QDs when attached to baculoviral vectors can
effectively enter and label the cells. This is an indication of its
possible application in monitoring the transduction efficiency
in baculovirus-mediated gene therapy. Fahmi and Chang [118]
synthesised a double layer (alkyl-capping AgInS2-Zn) QDs, the
lkyl layer consists of terminal groups (carboxyl and thiols) which
erved as reactive sites for other materials. The resultant DL-alkyl
AIS QD was conjugated with folate for staining Human liver
HEPG2) and human breast (MCF-7) cancer cells. Confocal imaging
evealed the folate conjugated ZAIS QDs were successfully docked
t the tumour site. PEG conjugated Zn-doped AgInS2 QDs dis-
layed good water stability in water and PBS. When coated with
ilica, the cell imaging demonstration of the resultant material
as successful [119]. Liu et al. [120] in their study found peptide
onjugated CISe/ZnS QDs to be good tumour targeting imaging
robes.
More research work is still required in the in vivo and in
itro applications of CIS/ZnS, CISe/ZnS, AIS/ZnS, AISe/ZnS QDs [34].
mprovement in technology and instrumentation reveals the lim-
tations of each of this imaging techniques. However, solutions to
hese limitations are being provided from time to time as more
esearches are been carried out.
.3. Drug delivery
In cancer therapy, the effectiveness of a drug is measured by
ts ability to deliver the appropriate quantity of the drug at a con-
rolled rate and time to the desired site. Toxicity, poor targeting
nd non-selectiveness are the side effects accompanying the use
f anti-cancer drugs [121]. Ternary QDs base drug delivery system
nsures the release of a drug at the particular site or organ at a
ontrolled rate which is far more preferable over the conventional
ncontrolled release throughout the body. Increased capacity for
rug loading, controlled release profile and improved therapeutic
ndex of the drugs makes QDs a good candidate for drug delivery
ystems [122]. Using certain coupling strategies, the QDs can
e functionalised by a range of cancer-targeting moieties such
s anti-cancer drugs, folic acid and aptamer. QDs drug delivery
ystem have unique ways of releasing drugs for effective target
rug delivery. At the beginning it comes as an outbreak release
nd then shows a constant release over a stretch of time. This
eans the efficiency of the drugs can be maintained over a long
tretch of time, at limited concentration, fewer intervals, and
ower doses thereby reducing the side effects of these drugs
n the patient [123]. For effective and concise target delivery,
onitoring of pH, temperature and biological reactions is very
mportant.
For a QDs to be efficient in drug delivery systems it should
ave the following properties [124]: (i) It must not interact with
he drug (ii) the drug loading ability and encapsulation efficiency
hould be high (iii) long residence time in vivo (iv) excellent
iocompatibility and should be non-toxic (v) good mechanical
trength, stability and shape. Several works have been reported
n drug delivery systems using QDs; Wu et al. [125] reported
he covalent coupling of anticancer drug, methotrexate (MTX)
o the surface of AgInS2/ZnS QDs. Result from the study reveals
hat the QD-MTX conjugate displayed good biocompatibility in
TT assays and showed negligible cytotoxicity in HeLa cells. CIS
Ds bonded with doxorubicin (DOX), an anti-cancer drug was re-
orted to effectively deliver DOX to the targeted cancer cells [59].
n another study, Girma et al. [126] described the conjugation of
ynthesised CuFeS2 NPs with anti-cancer drug cisplatin (IV). The
tudy revealed that the CuFeS2 NPs drug conjugate reduced the
ide effect of the drug on normal tissues..4. Photo-therapeutic applications
The aim of biomedical researchers is to develop alternative
ethods for cancer treatment that are safe, efficient and cost
ffective. Photo-therapeutic methods such as photodynamic ther-
py (PDT) and photo-thermal therapy (PTT) are preferred due
o the following reasons; (i) surgery is not required (ii) non-
nvasiveness (iii) it is cost effective and (iv) little or no side
ffect [127]. Photodynamic therapy is a treatment procedure that
ses a photosensitiser selectively localised to a target tissue fol-
owed by light irradiation. The photosensitiser has the ability to
hange molecular oxygen from the triplet oxygen to the singlet
tate (1O2) when exposed to single wavelength light. The en-
rgy released for the transition from the triplet ground state to
he singlet excited state leads to the formation of by-products
peroxide, radicals) and results in the destruction of surrounding
umours and cancer cells via the singlet oxygen. Optical proper-
ies of QDs have been improved by the introduction of ternary
Ds. Due to this improvement, these QDs penetrates more into
he tissues as they do not experience much barrier from blood,
igments and melanin [128]. PTT photo-therapeutic technique
nvolves the generation of hyperthermia from near infra-red (NIR)
hotoabsorbers for the destruction of surrounding cancer cells.
his technique destroys cancerous cells in primary tumour or
hen combined with other therapeutic technique. The use of QDs
s a therapeutic agent in PTT offers advantages such as spatiotem-
oral selectivity, rapid treatment, affordability and minimal side
ffect [17,129]. Fig. 5 shows a schematic illustration of the use
f ZCIS for imaging and therapy applications. Other PTT agents
ave been employed including; gold nanoparticles [130,131] due
o its ability to enhance the effect of radiotherapy on tumours,
arbon nanorods [132] due to their excellent light to heat energy
onversion and nano scale metal organic particles (NMOPs) [133]
see Fig. 6).
. Toxicity of ternary I-III-VI QDs
Toxicity of QDs has been a major challenge over the years (Zhu
t al. 2020). The level of toxicity would determine the intrinsic
oxic behaviour of the QDs. The surface modification, the stability
f the ligands, pharmacokinetics, method of administration etc.
re to be cautiously considered [135]. Furthermore, it is important
hat the QDs should be eradicated from the body as soon as
ossible after administration.
In spite of all the progress and achievement in the study of
Ds, their toxicity is not yet clearly understood. in vitro and in
ivo studied has been carried out at various concentrations, size
nd structure, exposure time etc. thereby making it difficult to
redict the toxic nature of newly synthesised QDs. Toxicity of QDs
epends on certain properties such as size, charge, concentration,
uter functional group, and oxidative and photolytic activity [136,
37]. The ability to eliminate QDs as fast as possible from the
ody is a major factor in determining the clinical application of
ny in vivo treatment. Studies have shown that QDs with a size
5 nm can be removed through renal pathways, while those
ithin the range of 10–20 nm can be consumed by the liver and
hose with sizes > 200 nm can be filtered through the reticulo-
ndothelial system [138–140]. On introduction to the cancer cell,
he QDs spread around the cell, they get consumed by the cancer
ell, and localised intracellularly so that therapeutic action can
ccur [17].
However ternary I–III–VI QDs have exhibited lower toxicity
ver time as several studies have attested to it. Shinchi et al. [141]
bserved low toxicity of AIS/ZnS NPs when attached to sugar-
hain-fluorescent NPs for imaging and biosensing applications.
he study further reveals the suitability of this QDs for bioimaging































Fig. 6. Scheme illustration of ZCIS QDs used as theranostic nanomedicines with intrinsic fluorescence/MSOT imaging and PTT/PDT therapy abilities [134].pplications. CIS/Zns QDs have been found to exhibit minimal
n vivo local toxicity when adult zebra fish were exposed to
he freshly prepared QDs. Girmal et al. [142] in their study also
bserved reduced local toxicity when CuFeS2 was injected into
an adult zebra fish. Their desirable properties such as tunable
photoluminescence, high PLQY, high chemical and photo stability
might have contributed to this [17,143].
Ternary QDs-drug conjugate can be easily taken up and ab-
sorbed by the body cells when applied due to their optical and
structural properties such as excellent luminescence, direct band
gap, non/low toxicity, large stokes shift [28,144]. Also, conjugate
system has the ability of delivering the cancer drug to where it
will be most effective and quick elimination without harming the
healthy cells [9].
Conclusively, more work studies are still required to fully
comprehend the toxicity of ternary I–III–VI QDs. Study on exper-
imental conditions, dosages, experimental cell lines for in vitro
studies, and animal models for in vivo studies should shed more
ight on the toxicity of these QDs as they are not totally benign
o living systems.
. Conclusion and future perspective
In this review, we discussed the synthesis, properties and
pplications of ternary QDs with major focus on the recent de-
elopment of ternary I–III–VI core/shell QDs for cancer man-
gement. The synthetic methods, surface modification, biocon-
ugation and applications relating to cancer treatment such as
iosensing, bioimaging, drug delivery, diagnosis and therapy have
een described. Ternary QDs has gained much attention among
esearchers due to their low toxicity (devoid of Cd and Pb atoms),
unable emission and broad absorption spectra from the range of
V to near IR, higher QY and large stoke shift. These excellent
roperties enable their application in cancer phototheranostic
rocedure such as PDT, PTT, bioimaging and biosensors. The use
f these non-toxic ternary QDs as photosensitisers in PDT has
vercome the problem of poor tissue penetration during cancer
reatment due to their ability to act as a good electron acceptor
nd donor to produce ROS and 1O2 for PDT [145,146]. The ex-
itation wavelength in the NIR range exhibited by I–III–VI QDs
nables deeper penetration into tissues when applied in PDT.
QD nanoprobes have also been considered suitable for biosen-
ors, MRI and drug delivery systems in the therapy and man-
gement of cancers. Furthermore, in addition to careful material
omposition, bioconjugation of ternary QDs with engineered sur-
ace material such as protein, peptides etc. can lead to new
iomedical applications. As the biological application of QDs is
xpanding as the days go by, effort should be intensified towardsthe design of multifunctional QDs for multipurpose therapeutic
applications. For example, developing a QD that can both serve as
a contrasting agent together with photodynamic therapy would
be of immense benefit. The mechanism involved in the synthesis
procedure still needs to be understood better so that proper-
ties such as morphology, quantum yield and photoluminescence
could be effectively controlled. Even though ternary QDs shows
low toxicity when compared to binary QDs, toxicity can further
be reduced using surface modification materials such as engi-
neered protein, biocompatible polymers etc. Research should also
focus on the design of QDs for the effective therapeutic control
and monitoring of malignant cells. The development of novel
non-toxic ternary QDs will definitely create the possibility of
challenging the frontier of present cancer research and contribute
to the success of clinical trials. Existing synthetic strategies and
routes can be employed to achieve the synthesis of other groups
of ternary I–II–VI QD NPs in the nearest future.
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